114 related articles for article (PubMed ID: 22425425)
1. A comparison of propofol and amobarbital for use in the Wada test.
Magee JA; Pender NP; Abrahams S; Thornton J; Delanty N; Fortune GM
Seizure; 2012 Jun; 21(5):399-401. PubMed ID: 22425425
[TBL] [Abstract][Full Text] [Related]
2. Bilateral Wada test: amobarbital or propofol?
Curot J; Denuelle M; Busigny T; Barragan-Jason G; Kany M; Tall P; Marlat F; Fabre N; Valton L
Seizure; 2014 Feb; 23(2):122-8. PubMed ID: 24252808
[TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of propofol as a replacement for amobarbital in intracarotid Wada testing of presurgical patients with epilepsy.
McCleary K; Barrash J; Granner M; Manzel K; Greider A; Jones R
Epilepsy Behav; 2018 Jan; 78():25-29. PubMed ID: 29169082
[TBL] [Abstract][Full Text] [Related]
4. Alternatives to sodium amobarbital in the Wada test.
Patel A; Wordell C; Szarlej D
Ann Pharmacother; 2011 Mar; 45(3):395-401. PubMed ID: 21325100
[TBL] [Abstract][Full Text] [Related]
5. Selective posterior cerebral artery amobarbital test: a predictor of memory following subtemporal selective amygdalohippocampectomy.
Catapano JS; Whiting AC; Wang DJ; Hlubek RJ; Labib MA; Morgan CD; Brigeman S; Fredrickson VL; Cavalcanti DD; Smith KA; Ducruet AF; Albuquerque FC
J Neurointerv Surg; 2020 Feb; 12(2):165-169. PubMed ID: 31320550
[TBL] [Abstract][Full Text] [Related]
6. Advantages of methohexital over amobarbital in determining hemispheric language and memory lateralization in the Wada test - A retrospective study.
Conradi N; Rosenberg F; Biermann L; Haag A; Hermsen A; Gorny I; von Podewils V; Gurschi M; Keil F; Hattingen E; Menzler K; Bauer S; Schubert-Bast S; Knake S; Rosenow F; Strzelczyk A
Epilepsy Behav; 2020 Dec; 113():107551. PubMed ID: 33246234
[TBL] [Abstract][Full Text] [Related]
7. Intracarotid propofol testing: a comparative study with amobarbital.
Mikati MA; Naasan G; Tarabay H; El Yamen S; Baydoun A; Comair YG
Epilepsy Behav; 2009 Mar; 14(3):503-7. PubMed ID: 19162226
[TBL] [Abstract][Full Text] [Related]
8. Intracarotid etomidate is a safe alternative to sodium amobarbital for the Wada test.
Mariappan R; Manninen P; McAndrews MP; Cohn M; Tai P; Valiante T; Venkatraghavan L
J Neurosurg Anesthesiol; 2013 Oct; 25(4):408-13. PubMed ID: 23686105
[TBL] [Abstract][Full Text] [Related]
9. Language assessment in Wada test: comparison of methohexital and amobarbital.
Loddenkemper T; Möddel G; Dinner DS; Kim H; Schuele SU; Alexopoulos AV; Kotagal P; Lüders HO
Seizure; 2009 Nov; 18(9):656-9. PubMed ID: 19800265
[TBL] [Abstract][Full Text] [Related]
10. Intracarotid propofol test for speech and memory dominance in man.
Takayama M; Miyamoto S; Ikeda A; Mikuni N; Takahashi JB; Usui K; Satow T; Yamamoto J; Matsuhashi M; Matsumoto R; Nagamine T; Shibasaki H; Hashimoto N
Neurology; 2004 Aug; 63(3):510-5. PubMed ID: 15304583
[TBL] [Abstract][Full Text] [Related]
11. Prediction of verbal memory decline after epilepsy surgery in children: effectiveness of Wada memory asymmetries.
Lee GP; Westerveld M; Blackburn LB; Park YD; Loring DW
Epilepsia; 2005 Jan; 46(1):97-103. PubMed ID: 15660774
[TBL] [Abstract][Full Text] [Related]
12. [Tolerability and adverse effects of propofol in the Wada test].
Castro-Macías JI; Pérez-Reyes SP; García-Cazarez R; Pérez-Careta MC; Díaz-Campos MO; Salazar-Hörner DL; Preciado-Gutiérrez OU; Ruíz-Velázquez F
Rev Neurol; 2021 Mar; 72(5):151-156. PubMed ID: 33616197
[TBL] [Abstract][Full Text] [Related]
13. Cerebral amobarbital sodium distribution during Wada testing: utility of digital subtraction angiography and single-photon emission tomography.
Castillo M; Mukherji SK; McCartney WH
Neuroradiology; 2000 Nov; 42(11):814-7. PubMed ID: 11151686
[TBL] [Abstract][Full Text] [Related]
14. Propofol as a substitute for amobarbital in Wada testing.
Chiu AH; Bynevelt M; Lawn N; Lee G; Singh TP
J Clin Neurosci; 2015 Nov; 22(11):1830-2. PubMed ID: 26188665
[TBL] [Abstract][Full Text] [Related]
15. Propofol, amobarbital… is it the substance that matters, or the question about the role of the Wada test in brain tumor patients?
Schaller K
World Neurosurg; 2011; 75(3-4):428-30. PubMed ID: 21600484
[No Abstract] [Full Text] [Related]
16. Wada testing in pediatric patients by use of propofol anesthesia.
Masters LT; Perrine K; Devinsky O; Nelson PK
AJNR Am J Neuroradiol; 2000 Aug; 21(7):1302-5. PubMed ID: 10954283
[TBL] [Abstract][Full Text] [Related]
17. The intracarotid amobarbital procedure: when is it worth repeating?
Whitman LA; Morrison CE; Becske T; Barr WB; Carlson C
Epilepsia; 2012 Apr; 53(4):721-7. PubMed ID: 22309160
[TBL] [Abstract][Full Text] [Related]
18. Reduced anesthetization during the intracarotid amobarbital (Wada) test in patients taking carbonic anhydrase-inhibiting medications.
Bookheimer S; Schrader LM; Rausch R; Sankar R; Engel J
Epilepsia; 2005 Feb; 46(2):236-43. PubMed ID: 15679504
[TBL] [Abstract][Full Text] [Related]
19. The base rate of Wada test failure.
Kemp S; Wilkinson K; Caswell H; Reynders H; Baker G
Epilepsy Behav; 2008 Nov; 13(4):630-3. PubMed ID: 18715550
[TBL] [Abstract][Full Text] [Related]
20. Effects of topiramate on memory performance on the intracarotid amobarbital (Wada) test.
Kipervasser S; Andelman F; Kramer U; Nagar S; Fried I; Neufeld MY
Epilepsy Behav; 2004 Apr; 5(2):197-203. PubMed ID: 15123021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
